Products for Research Use Only
RegisterLogin

Girentuximab

CAT: 0804-HY-P99023-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99023-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Girentuximab (G250) is a chimeric monoclonal antibody that binds carbonic anhydrase IX (CAIX), a cell surface glycoprotein ubiquitously expressed in clear cell renal cell carcinoma (ccRCC) [1].
CAS Number
916138-87-9
Product Name Alternative
G250; cG250
UNSPSC
12352203
Target
Carbonic Anhydrase
Type
Inhibitory Antibodies
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/girentuximab.html
Purity
99.90
Solubility
H2O
Smiles
[Girentuximab]
Molecular Weight
(144.62 kDa)
References & Citations
[1]Chamie K, et al. Adjuvant Weekly Girentuximab Following Nephrectomy for High-Risk Renal Cell Carcinoma: The ARISER Randomized Clinical Trial. JAMA Oncol. 2017;3 (7) :913-920.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Isoform
CA IX

Alternative Products

CatalogName
abx831190-01Girentuximab
T9901A-215-01Girentuximab MMAE
GTR18337594-01Girentuximab Antibody
E55B0953Girentuximab (Reference antibody)
DHH37201Research Grade Girentuximab
GTR18578302-01Girentuximab MMAE Antibody
ICH5013-1gGirentuximab Biosimilar - Research Grade
GTR18697647-01Girentuximab Chimeric Monoclonal Antibody
MBS3030375-01Girentuximab Biosimilar - Research Grade
KBI1363KRIBIOLISA™ Girentuximab (RENCAREX) ELISA

Popular Products